Robin H Lachmann Selected Research

burosumab

1/2023	Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment.
10/2022	Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study.
1/2021	Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension.
1/2018	A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robin H Lachmann Research Topics

Disease

8	Fabry Disease (Fabry's Disease) 01/2018 - 01/2013
6	Gaucher Disease (Gaucher's Disease) 10/2021 - 04/2003
3	Osteoarthritis 01/2023 - 01/2018
3	Pain (Aches) 01/2023 - 01/2018
3	Niemann-Pick Diseases (Niemann Pick Disease) 01/2023 - 01/2018
3	Fatigue 01/2023 - 01/2021
3	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2017 - 08/2004
3	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2016 - 04/2009
2	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 10/2022 - 01/2018
2	Hypophosphatemia 10/2022 - 01/2018
2	Inborn Genetic Diseases (Disease, Hereditary) 10/2021 - 03/2010
2	Fibrosis (Cirrhosis) 09/2020 - 01/2019
2	Phenylketonurias (Phenylketonuria) 01/2019 - 04/2011
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 05/2015 - 05/2013
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2014 - 05/2013
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023
1	Dyslipidemias (Dyslipidemia) 01/2023
1	Glycogen Storage Disease IIIA 01/2022
1	Osteonecrosis (Kienbock's Disease) 10/2021
1	Hepatomegaly 09/2020
1	Hypertrophy 01/2019
1	Cicatrix (Scar) 01/2019
1	Epilepsy (Aura) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Intellectual Disability (Idiocy) 01/2019
1	Muscular Diseases (Myopathy) 01/2018
1	Nephrocalcinosis 01/2018
1	Vacuolar myopathy 01/2018
1	Muscle Weakness 01/2018
1	Colitis 01/2017
1	Crohn Disease (Crohn's Disease) 01/2017
1	Granuloma 01/2017
1	Stroke (Strokes) 05/2015
1	Renal Insufficiency (Renal Failure) 05/2015
1	Chronic Renal Insufficiency 02/2015
1	Cysts 02/2015
1	Inborn Urea Cycle Disorders 01/2014
1	Kidney Diseases (Kidney Disease) 05/2013
1	Aortic Valve Stenosis (Aortic Stenosis) 05/2013
1	Hypertension (High Blood Pressure) 05/2013
1	Amyloidosis 05/2013
1	Cerebrotendinous Xanthomatosis 12/2012
1	Heart Diseases (Heart Disease) 10/2012
1	Methylmalonic acidemia 05/2012
1	Maternal Death 05/2012
1	Homocystinuria 05/2012
1	Glutaric Acidemia I 05/2012
1	Ornithine Carbamoyltransferase Deficiency Disease 05/2012
1	Propionic Acidemia 05/2012
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2010
1	Injection Site Reaction 03/2010
1	Parkinson Disease (Parkinson's Disease) 07/2009
1	Central Nervous System Diseases (CNS Diseases) 05/2009
1	Glycogen Storage Disease Type II (Pompe's Disease) 10/2004

Drug/Important Bio-Agent (IBA)

5	LipidsIBA 01/2023 - 08/2004
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 02/2009
5	miglustat (Zavesca)FDA Link 01/2016 - 04/2003
4	burosumabIBA 01/2023 - 01/2018
3	olipudase alfaIBA 01/2023 - 01/2018
2	AcidsIBA 01/2023 - 01/2018
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2023 - 01/2018
2	Fibroblast Growth Factor-23IBA 10/2022 - 01/2018
2	Monoclonal AntibodiesIBA 10/2022 - 01/2018
2	SphingolipidsIBA 01/2019 - 12/2014
2	GalactosidasesIBA 05/2015 - 02/2015
2	Proteins (Proteins, Gene)FDA Link 02/2015 - 05/2013
1	Carbon MonoxideIBA 01/2023
1	Opioid Analgesics (Opioids)IBA 10/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	EnzymesIBA 09/2020
1	SphingomyelinsIBA 09/2020
1	Lysergic Acid Diethylamide (LSD)IBA 01/2020
1	Amylases FDA Link 01/2018
1	globotriaosyl lysosphingolipidIBA 01/2018
1	polyglucosanIBA 01/2018
1	Phosphates (Orthophosphate)IBA 01/2018
1	CalciumIBA 01/2018
1	Parathyroid Hormone (Parathormone)IBA 01/2018
1	globotriaosylceramide (globotriosylceramide)IBA 05/2015
1	agalsidase beta FDA Link 05/2015
1	mesoglycanIBA 03/2014
1	AmmoniaIBA 01/2014
1	Amyloid (Amyloid Fibrils)IBA 05/2013
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2013
1	CholesterolIBA 12/2012
1	LyasesIBA 05/2012
1	Ornithine Carbamoyltransferase (Ornithine Transcarbamylase)IBA 05/2012
1	Phenylalanine (L-Phenylalanine)FDA Link 04/2011
1	mipomersenIBA 03/2010
1	LDL Receptors (LDL Receptor)IBA 03/2010
1	LDL CholesterolIBA 03/2010
1	Glucosylceramidase (Glucocerebrosidase)IBA 07/2009
1	alpha-Glucosidases (Acid Maltase)IBA 10/2004

Therapy/Procedure

8	Enzyme Replacement Therapy 01/2023 - 05/2009
4	Therapeutics 10/2021 - 04/2009
1	Splenectomy 10/2021
1	Protein-Restricted Diet (Diet, Protein Restricted) 04/2011